Case-Based Roundtable Meeting Spotlight October 1 2021 | Case-Based Roundtable Meetings Spotlight

Roundtable Discussion: Vesole Looks at Treatment Options in Transplant-Eligible Multiple Myeloma

October 07, 2021

Clinical Articles

A 51-year-old man presented with worsening fatigue on exertion and pallor with an ECOG performance score of 1. He eventually received a diagnosis of stage II standard-risk multiple myeloma after testing and examination.

Roundtable Discussion: Dreicer Speaks to the Importance of Therapeutic Sequencing in mCRPC

October 07, 2021

Clinical Articles

A patient with metastatic castration-resistant prostate cancer received external beam radiation therapy and androgen deprivation therapy became asymptomatic, then presented with hip pain and urinary frequency 6 months later.

Roundtable Roundup: Polling Physicians on Use of Durvalumab Plus EP in SCLC

October 06, 2021

Clinical Articles

During separate virtual live events, Matthew A. Gubens, MD, MS, and Rodolfo Bordoni, MD, discussed the CASPIAN trial of durvalumab plus platinum therapy and etoposide and whether the participants have used this regimen in patients with small cell lung cancer.

Roundtable Discussion: Quinn Compares Chemotherapy Treatments in mCRPC

October 06, 2021

Clinical Articles

David I. Quinn, MD, MBBS, PhD and other oncologists, discussed disease management and the option of using an osteoclast-targeting agent for a 75-year-old man with metastatic castration-resistant prostate cancer.